MS
AURA icon

Maven Securities’s Aura Biosciences AURA Stock Holding History

Maven Securities’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$335K Buy
+50,000
New +$287K 0.01% 372

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Maven Securities's AURA Position: Q1 2026 in Review

Maven Securities opened a new position in Aura Biosciences (AURA) in Q1 2026: 50,000 shares worth $335K. The stake represents 0.01% of the portfolio and ranks #372 among its holdings.

126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Maven Securities held 50,000 shares of Aura Biosciences worth $335K as of Q1 2026.
  • Aura Biosciences was a new Maven Securities position in Q1 2026.
  • Aura Biosciences made up 0.01% of Maven Securities's portfolio in Q1 2026, its #372 holding.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Maven Securities's 13F filing for Q1 2026, filed 15 May 2026.